Ana Belén Romero

Comparative effectiveness of switching to alternative tumour necrosis factor (TNF) antagonists versus switching to rituximab in patients with rheumatoid arthritis who failed previous TNF antagonists: the MIRAR Study

Juan J. Gómez‐Reino, José Ramón Maneiro, Jorge Rodríguez Ruiz et al. · Annals of the Rheumatic Diseases · 2012 · 79 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

Safety and Efficacy of Tofacitinib in Patients with Active Psoriatic Arthritis: Interim Analysis of OPAL Balance, an Open-Label, Long-Term Extension Study

Peter Nash, Laura C. Coates, Alan Kivitz et al. · Rheumatology and Therapy · 2020 · 62 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

GMP-Compliant Manufacturing of NKG2D CAR Memory T Cells Using CliniMACS Prodigy

Lucía Fernández, Adrián Fernández, Isabel Mirones et al. · Frontiers in Immunology · 2019 · 60 citations · Full text

Life Sciences, Biotechnology, Immunology +17

Tofacitinib as monotherapy following methotrexate withdrawal in patients with psoriatic arthritis previously treated with open-label tofacitinib plus methotrexate: a randomised, placebo-controlled substudy of OPAL Balance

Peter Nash, Philip J. Mease, Dona Fleishaker et al. · The Lancet Rheumatology · 2020 · 22 citations

Medicine, Pharmacology, Pharmacotherapy +8

The role of early natural killer cell adoptive infusion before engraftment in protecting against human herpesvirus<scp>‐6B</scp> encephalitis after naïve <scp>T</scp>‐cell‐depleted allogeneic stem cell transplantation

Mercedes Gasior Kabat, Cristina Ferreras, Raquel de Paz et al. · Transfusion · 2021 · 19 citations

Medicine, Hematology, Immunology +17